When Scientists Think Like Accountants

Scientists and technologists in industry complain about being subjected to accountants, but, as Mark Twain would point out, they do nothing about it. In self-defense they learn to read balance sheets and to use the jargon of accountants, but they regard these as being trivial matters not worthy of serious thought. They therefore pay little or no attention to the assumptions that are buried deep below practice and of which accountants themselves seldom are conscious—assumptions that, to

Written byDw Budworth
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientists and technologists in industry complain about being subjected to accountants, but, as Mark Twain would point out, they do nothing about it. In self-defense they learn to read balance sheets and to use the jargon of accountants, but they regard these as being trivial matters not worthy of serious thought. They therefore pay little or no attention to the assumptions that are buried deep below practice and of which accountants themselves seldom are conscious—assumptions that, to a scientist or technologist, are grossly out of date. These assumptions are based on a model of a company that is set up to manufacture or supply a product that remains unchanged both in itself and in the method by which it is manufactured for an indefinite (presumably infinite) life.

Yet companies that want to stay in business must continually introduce new products and constantly update the methods by which they produce and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies